Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

PrimeAge

Financiado

Age-dependent nutrient priming of the pre-metastatic niche

Metastasis is the leading cause of death in cancer patients. Aging is an important risk factor for metastasis formation, yet the underlying processes remain poorly understood. Given the increase in aging populations worldwide, elu... ver más

30/09/2026

VLAAMS INSTITUUT...

192K€

Presupuesto del proyecto: 192K€

Líder del proyecto

VIB VZW No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-04-24

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2023-PF-01-01: MSCA Postdoctoral Fellowships 2023

I+D

Cerrada hace 1 año

0% 100% 100%

1 Participantes

VLAAMS INSTITUUT BIOTECHNOL...

191.76K€ | Lider

Proyectos interesantes

PRE2020-092033 Developmental mechanisms of disease, aging, metabolism and c... 99K€ Cerrado

RYC-2017-22335 Crosstalks between metabolism, aging and cancer 309K€ Cerrado

PID2021-127645OA-I00 PAPEL DEL TEJIDO ADIPOSO EN EL DESARROLLO DE HETEROGENEIDAD... 206K€ Cerrado

JCI-2011-10960 Caracterización del secretoma de células tumorales senescent... 96K€ Cerrado

RYC2021-031776-I Molecular Mechanisms Underlying the Hallmarks of Cancer and... 236K€ Cerrado

PRE2020-095127 EL CONTROL FISIOLOGICO DEL EJE NUTRIENTES-MTOR Y SU DESREGUL... 99K€ Cerrado

Últimas noticias

29-11-2024: IDAE En las últimas 48 horas el Organismo IDAE ha otorgado 4 concesiones

29-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 2 concesiones

29-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 37 concesiones

Duración del proyecto: 29 meses Fecha Inicio: 2024-04-24
Fecha Fin: 2026-09-30

Líder del proyecto

VIB VZW

TRL 4-5

Presupuesto del proyecto 192K€

Descripción del proyecto Metastasis is the leading cause of death in cancer patients. Aging is an important risk factor for metastasis formation, yet the underlying processes remain poorly understood. Given the increase in aging populations worldwide, elucidating mechanisms of age-promoted metastasis formation is an important and timely topic addressed in this proposal. Recently, the Fendt group has pioneered the concept that tumor-secreted factors (TSF) induce nutrient priming of distant organs for metastasis formation. This concept is exemplified by adaptations in lipid metabolism of target organs, triggering a pro-metastatic signaling pathway in invading tumor cells. I propose that nutrient priming is age-dependent, as the metabolism changes with age, contributing to the enhanced risk of metastasis formation in the elderly. I will investigate this concept using melanoma as a prototypic cancer of age-dependent, aggressive metastatic behavior. I will address 3 specific objectives: (1) Identify age-dependent metabolic response of distant organs to TSF using mass spectrometry imaging-based spatial metabolomics in young and aging mouse models, and corroborate my findings in melanoma patients. (2) Elucidate molecular mechanisms whereby identified metabolites promote the pre-metastatic potential of the distant niche by applying genetic screens as well as multi-omics and functional assays to spheroid models of metastasis. (3) Validate the therapeutic potential of intercepting age-specific metabolic priming using pharmacological and genetic perturbations in mouse melanoma models. Ultimately, I expect to identify age-specific metabolic adaptations in pre-metastatic niches and to document that these pathways provide targets for personalized therapy of metastatic tumors in the elderly. This ambitious proposal is based on my expertise in elucidating the instructive role of metabolites in cell fate and function, and on expert skills in cancer metabolism research that I will acquire in the Fendt lab.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores